Vaccine Research
Vaccine research at Statens Serum Institut goes back to the institute’s founding in 1902, when it was set up to produce antisera for Diphtheria. Research soon expanded to other epidemic diseases. Today the main effort is devoted to vaccines against tuberculosis, chlamydia, HIV and novel adjuvants to direct and potentiate the immune responses.